All products / DC31458
Tipranavir
Pack sizes and prices
| Pack size | Price |
|---|---|
| 100 mg | $650 USDRequest a quote / confirm availability → |
| 250 mg | $1,100 USDRequest a quote / confirm availability → |
| 500 mg | $2,200 USDRequest a quote / confirm availability → |
Confirm stock, lead time, shipping and final quotation with our team.
Product overview
Tipranavir is a nonpeptidic protease inhibitor. Tipranavir has the ability to inhibit the replication of viruses that are resistant to other protease inhibitors and it recommended for patients who are resistant to other treatments. Resistance to tipranavir itself seems to require multiple mutations. Tipranavir was approved by the Food and Drug Administration (FDA) on June 22, 2005, and was approved for pediatric use on June 24, 2008. Like lopinavir and atazanavir, it is very potent and is effective in salvage therapy for patients with some drug resistance.
For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.
Identity and specifications
| Catalog number | DC31458 |
|---|---|
| Product name | Tipranavir |
| CAS | 174484-41-4 |
| Molecular formula | C31H33F3N2O5S |
| Molecular weight | 602.66432 |
| Purity | >98% |
| SMILES | CCC[C@@]1(CCc2ccccc2)CC(O)=C([C@H](CC)c2cccc(NS(=O)(=O)c3ccc(C(F)(F)F)cn3)c2)C(=O)O1 |
Source-listed specifications; the batch COA applies.
Source and product documents
The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.
DC Chemicals — Tipranavir (DC31458)